Allied World Assurance (AWH) Appoints Celeste Fralick to its Board

Go back to Allied World Assurance (AWH) Appoints Celeste Fralick to its Board

Aspira Women’s Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors

February 28, 2022 8:14 AM EST

AUSTIN, Texas, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aspira Womens Health Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced the appointment of Celeste Fralick, Ph.D., to its Board of Directors, effective February 23, 2022.

Dr. Fralick is an accomplished executive with over four decades of data strategy experience. She brings to the Board a broad background in technology and specifically healthcare in several markets with both customer and industry-facing experience. She has expertise in statistics, cybersecurity, system engineering, disability analyses, risk management, operations, quality systems, global regulatory affairs, clinical management, biotechnology,... More